These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8449054)

  • 1. Treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing clarithromycin with erythromycin. Canada-Sweden Clarithromycin-Pneumonia Study Group.
    Chien SM; Pichotta P; Siepman N; Chan CK
    Chest; 1993 Mar; 103(3):697-701. PubMed ID: 8449054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia.
    Anderson G; Esmonde TS; Coles S; Macklin J; Carnegie C
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():117-24. PubMed ID: 1827098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized comparative study on the safety and efficacy of clarithromycin and erythromycin in treating community-acquired pneumonia.
    Jang TN; Liu CY; Wang FD; Yang SP; Fung CP
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Apr; 55(4):302-6. PubMed ID: 7796357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative efficacy and safety study of clarithromycin, roxithromycin and erythromycin stearate in mild pneumonia.
    Hatipoglu ON; Tasan Y
    Yonsei Med J; 2000 Jun; 41(3):340-4. PubMed ID: 10957888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, double-blind, multicenter study comparing clarithromycin extended-release with trovafloxacin in patients with community-acquired pneumonia.
    Sokol WN; Sullivan JG; Acampora MD; Busman TA; Notario GF
    Clin Ther; 2002 Apr; 24(4):605-15. PubMed ID: 12017405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral stepdown clarithromycin for treatment of patients with mild to moderate community-acquired pneumonia requiring hospitalization.
    Corrêa JC; Badaró R; Bumroongkit C; Mera JR; Dolmann AL; Juárez Martínez LG; Mayrinck LR; Tamez R; Yang JY
    Clin Ther; 2003 May; 25(5):1453-68. PubMed ID: 12867221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open, randomized, comparative study of clarithromycin and erythromycin in the treatment of children with community-acquired pneumonia.
    Lee PI; Wu MH; Huang LM; Chen JM; Lee CY
    J Microbiol Immunol Infect; 2008 Feb; 41(1):54-61. PubMed ID: 18327427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults.
    Mathers Dunbar L; Hassman J; Tellier G
    Clin Ther; 2004 Jan; 26(1):48-62. PubMed ID: 14996517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia.
    Gotfried MH; Dattani D; Riffer E; Devcich KJ; Busman TA; Notario GF; Palmer RN
    Clin Ther; 2002 May; 24(5):736-51. PubMed ID: 12075942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
    Tellier G; Niederman MS; Nusrat R; Patel M; Lavin B
    J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study.
    Tamm M; Todisco T; Feldman C; Garbino J; Blasi F; Hogan P; de Caprariis PJ; Hoepelman IM
    Clin Microbiol Infect; 2007 Feb; 13(2):162-171. PubMed ID: 17328728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
    Bradley JS; Arguedas A; Blumer JL; Sáez-Llorens X; Melkote R; Noel GJ
    Pediatr Infect Dis J; 2007 Oct; 26(10):868-78. PubMed ID: 17901791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate.
    Block S; Hedrick J; Hammerschlag MR; Cassell GH; Craft JC
    Pediatr Infect Dis J; 1995 Jun; 14(6):471-7. PubMed ID: 7667050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial.
    Lebel MH; Mehra S
    Pediatr Infect Dis J; 2001 Dec; 20(12):1149-54. PubMed ID: 11740322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia.
    Poirier R
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():109-16. PubMed ID: 1827096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection.
    Bradbury F
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():153-62. PubMed ID: 8396087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections.
    Neu HC; Chick TW
    Chest; 1993 Nov; 104(5):1393-9. PubMed ID: 8222794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clarithromycin in the treatment of community-acquired lower respiratory tract infections.
    Anderson G
    J Hosp Infect; 1991 Sep; 19 Suppl A():21-7. PubMed ID: 1684979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults.
    Drehobl MA; De Salvo MC; Lewis DE; Breen JD
    Chest; 2005 Oct; 128(4):2230-7. PubMed ID: 16236879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and efficacy of clarithromycin in patients with Legionella pneumonia.
    Hamedani P; Ali J; Hafeez S; Bachand R; Dawood G; Quereshi S; Raza R; Yab Z
    Chest; 1991 Dec; 100(6):1503-6. PubMed ID: 1835689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.